Treatment of Intracranial Infection Caused by Methicillin-Resistant Staphylococcus epidermidis with Linezolid Following Poor Outcome of Vancomycin Therapy: A Case Report and Literature Review

Treatment of Intracranial Infection Caused by Methicillin-Resistant Staphylococcus epidermidis with Linezolid Following Poor Outcome of Vancomycin Therapy: A Case Report and Literature Review

Xinyang Fu,1,&ast; Zhiqiang Lin,1,&ast; Sumei Chen,2 Limian Hong,1 Xueping Yu,2 Shuifa Wu1 1Department of Pharmacy, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, People’s Republic of China; 2Department of Infectious Disease, Quanzhou First Hospital Affili...

Full description

Bibliographic Details
Main Authors:	Fu X, Lin Z, Chen S, Hong L, Yu X, Wu S
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-07-01
Series:	Infection and Drug Resistance
Subjects:	auc/mic trough concentration intracranial infection vancomycin linezolid
Online Access:	https://www.dovepress.com/treatment-of-intracranial-infection-caused-by-methicillin-resistant-st-peer-reviewed-fulltext-article-IDR

Similar Items

In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey
by: Alicem Tekin, et al.
Published: (2014-09-01)

Evaluation of the Association between Trough and Area Under the Curve to Minimum Inhibitory Concentration Ratio (AUC24/MIC) of Vancomycin in Infected Patients with Methicillin Resistant Staphylococcus aureus (MRSA)
by: Ayda Esmaeili, et al.
Published: (2021-06-01)

Cost-effectiveness of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant staphylococcus aureus
by: Adão R. L. Machado, et al.

Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus
by: Hideo Kato, et al.
Published: (2021-03-01)

The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
by: Moeko Tsutsuura, et al.
Published: (2021-02-01)

Dynamic Changes of Staphylococcus aureus Susceptibility to Vancomycin, Teicoplanin, and Linezolid in a Central Teaching Hospital in Shanghai, China, 2008–2018
by: Ying Jian, et al.
Published: (2020-05-01)

Clinical outcomes of linezolid and vancomycin in patients with nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus stratified by baseline renal function: a retrospective, cohort analysis
by: Ping Liu, et al.
Published: (2017-05-01)

In vitro activity of daptomycin & linezolid against methicillin resistant Staphylococcus aureus & vancomycin resistant enterococci isolated from hospitalized cases in Central India
by: Sheetal Chitnis, et al.
Published: (2013-01-01)

In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus
by: Weifeng Yang, et al.
Published: (2018-05-01)

Vancomycin, linezolid and daptomycin susceptibility pattern among clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) from Sub- Himalyan Center
by: Afzal Husain, et al.
Published: (2018-04-01)

Intravitreal linezolid in the management of vancomycin-resistant enterococcal endophthalmitis
by: Olufemi Emmanuel Babalola
Published: (2020-12-01)

Evolution of Multi-Resistance to Vancomycin, Daptomycin, and Linezolid in Methicillin-Resistant Staphylococcus aureus Causing Persistent Bacteremia
by: Chih-Jung Chen, et al.
Published: (2020-07-01)

A Monocentric Retrospective Study of AUC/MIC Ratio of Vancomycin Associated with Clinical Outcomes and Nephrotoxicity in Patients with Enterococcal Infections
by: Wasan Katip, et al.
Published: (2021-08-01)

Reduced susceptibility to vancomycin and biofilm formation in methicillin-resistant Staphylococcus epidermidis isolated from blood cultures
by: Luiza Pinheiro, et al.
Published: (2014-11-01)

Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid-consumption
by: Flaminia Olearo, et al.
Published: (2021-02-01)

Investigation of the Minimal Inhibitory Concentration Values of Vancomycin, Teicoplanin and Linezolid among MRSA Isolated from Inpatients by E-test Method
by: Tuğrul HOŞBUL, et al.
Published: (2012-06-01)

In vitro Activity of Contezolid Against Methicillin-Resistant Staphylococcus aureus, Vancomycin-Resistant Enterococcus, and Strains With Linezolid Resistance Genes From China
by: Siheng Wang, et al.
Published: (2021-08-01)

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci
by: Kanchanapoom Termkiat, et al.
Published: (2005-01-01)

Therapeutic drug monitoring of vancomycin by AUCτ-MIC ratio in patients with chronic kidney disease
by: Ahmad Khoei, et al.
Published: (2019-01-01)

Pharmacodynamics Of Linezolid-Plus-Fosfomycin Against Vancomycin-Susceptible And -Resistant Enterococci In Vitro And In Vivo Of A Galleria mellonella Larval Infection Model
by: Qi C, et al.
Published: (2019-11-01)

Device-Associated Meningitis by Linezolid-Resistant Staphylococcus haemolyticus in a Vancomycin- Hypersensitive Patient
by: Priya Vijayan, et al.
Published: (2019-10-01)

Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia
by: Sameerah Aljohani, et al.
Published: (2020-10-01)

Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older
by: Wang Y, et al.
Published: (2021-06-01)

Vancomycin dosing and target attainment in children
by: David Hwang, et al.
Published: (2017-08-01)

Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe
by: Robby Markwart, et al.
Published: (2021-05-01)

Uso de linezolid para el tratamiento de recién nacidos con infecciones por Enterococcus faecium resistentes a la vancomicina Linezolid for the treatment of newborns infected with vancomycin-resistant Enterococcus faecium
by: G. Berberian, et al.
Published: (2009-03-01)

The need to assay the real MIC when making the decision to eradicate Staphylococcus aureus with vancomycin
by: Hanna Tomczak, et al.
Published: (2013-09-01)

Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range
by: Phillips CJ, et al.
Published: (2016-05-01)

Endocarditis due to vancomycin-resistant Enterococcus raffinosus successfully treated with linezolid: case report and review of literature Endocarditis por Enterococcus raffinosus resistente a vancomicina exitosamente tratada con linezolid: caso clínico y revisión de la literatura
by: A. Jasovich, et al.
Published: (2008-12-01)

An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients
by: Huang X, et al.
Published: (2021-04-01)

Genomic Insights Into Last-Line Antimicrobial Resistance in Multidrug-Resistant Staphylococcus and Vancomycin-Resistant Enterococcus
by: Adrianna M. Turner, et al.
Published: (2021-03-01)

The Use of Linezolid in the Treatment of Ventilator-Associated Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus
by: Büşra ERGÜT SEZER, et al.
Published: (2009-03-01)

Comparative efficacy of linezolid and vancomycin for endotracheal tube MRSA biofilms from ICU patients
by: Laia Fernández-Barat, et al.
Published: (2019-07-01)

Evaluation of body weight-based vancomycin therapy and the incidence of nephrotoxicity: a retrospective study in the northwest of China
by: Mo-Han Dong, et al.
Published: (2015-08-01)

Recurrent linezolid-resistant Enterococcus faecalis infection in a patient with pneumonia
by: Zhi-jian Yu, et al.
Published: (2015-01-01)

ORIGINAL ARTICLE: Detection of in-vitro Activity of Linezolid in Methicillin Resistant Staphylococcus aureus Infections by E-test
by: Lakshmi S. Kakhandki, et al.
Published: (2012-07-01)

Factors affecting a variability of serum vancomycin concentrations in clinical practice
by: Kostitsyna M.A., et al.
Published: (2017-08-01)

Evaluation of Vancomycin Minimum Inhibitory Concentration in the clinical isolates of Methicillin Resistant Staphylococcus aureus (MRSA)
by: Anitha T.K., et al.
Published: (2019-09-01)

Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit
by: Xiaodan Qian, et al.
Published: (2017-07-01)

Revisiting methicillin-resistant Staphylococcus aureus infections
by: Abdelkarim Waness
Published: (2010-01-01)